Similar findings for RIP3K were observed with the oncogenic fusion protein AML1-ETO but not for MLL-ENL-induced leukemia (Höckendorf et al., 2016), suggesting that RIP3K- mediated inflammasome activation and IL-1β secretion play a counteracting role in some but not all AML subtypes. Here, IL1B is linked to acute myeloid leukemia.